Zometa Alternatives Compared
| Zometa Remove Zometa from your drug comparison | Xgeva Remove Xgeva from your drug comparison | Denosumab Remove Denosumab from your drug comparison |
|---|
| Zometa zoledronic acid Remove Zometa from your drug comparison | Xgeva denosumab Remove Xgeva from your drug comparison | Denosumab Remove Denosumab from your drug comparison | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Zometa is only available as an injection for administration by a healthcare provider and is indicated for the treatment of hypercalcemia associated with cancer, osteolytic bone lesions of multiple... View more |
Xgeva is an injection that is administered every four weeks to prevent bone fractures in people with certain types of cancer or to lower calcium levels in people with high calcium levels caused by... View more |
Denosumab is an injection that can be self-administered once every six months for the treatment of osteoporosis. It has been associated with an increased risk of fractures on discontinuation... View more |
||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||
Ratings & Reviews |
||||||||||
Drug Class |
||||||||||
Side Effects |
||||||||||
|
Common side effects include: hypophosphatemia, hypokalemia, hypomagnesemia. See the full Zometa side effects document. |
Common side effects include: dermatitis, eczema, skin rash. See the full Xgeva side effects document. |
Commonly reported side effects include: dermatitis, eczema, skin rash. See the full denosumab side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Xgeva prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Generic Availability |
||||||||||
|
No |
No |
|||||||||
Dosage Form(s) Available |
||||||||||
|
|
N/A | ||||||||
Brand Names |
||||||||||
| Other zoledronic acid brands include: Aclasta, Reclast | Other denosumab brands include: Prolia | Prolia, Xgeva | ||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
||||||||||
|
N/A |
609.6 hours |
609.6 hours |
||||||||
CSA Schedule**View glossary of terms. |
||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
||||||||||
|
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
Category X
Not for use in pregnancy
See the full Pregnancy Warnings document. |
||||||||
Drug Interactions |
||||||||||
|
A total of 113 drugs are known to interact with Zometa:
|
A total of 236 drugs are known to interact with Xgeva:
|
A total of 236 drugs are known to interact with denosumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions |
||||||||||
First Approval Date |
||||||||||
|
February 22, 2002 |
June 01, 2010 |
N/A |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
||||||||||
|
N/A |
N/A |
N/A |
||||||||
More Information |
||||||||||
Consumer Resources |
||||||||||
Professional Resources |
||||||||||
Related Treatment Guide |
||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.